A Transfer Learning Based Approach for
Classification of COVID-19 and Pneumonia in CT
Scan Imaging
Gargi Desaiγ, Nelly Elsayed†, Zag Elsayed‡, Murat Ozer∗
School of Information Technology
University of Cincinnati
Cincinnati, Ohio, United States
γdesaigd@mail.uc.edu, †elsayeny@ucmail.uc.edu, ‡elsayezs@ucmail.uc.edu, ∗ozermm@ucmail.uc.edu
Abstract—The world is still overwhelmed by the spread of
the COVID-19 virus. With over 250 Million infected cases as
of November 2021 and affecting 219 countries and territories,
the world remains in the pandemic period. Detecting COVID-
19 using the deep learning method on CT scan images can
play a vital role in assisting medical professionals and decision
authorities in controlling the spread of the disease and providing
essential support for patients. The convolution neural network
is widely used in the field of large-scale image recognition.
The current method of RT-PCR to diagnose COVID-19 is time-
consuming and universally limited. This research aims to propose
a deep learning-based approach to classify COVID-19 pneumonia
patients, bacterial pneumonia, viral pneumonia, and healthy
(normal cases). This paper used deep transfer learning to classify
the data via Inception-ResNet-V2 neural network architecture.
The proposed model has been intentionally simplified to reduce
the implementation cost so that it can be easily implemented
and used in different geographical areas, especially rural and
developing regions.
Index Terms—Transfer learning, image classification, CT scan,
deep learning
I. INTRODUCTION
Emerging and resurfacing bacteria are universal challenges
for human health. Coronavirus is a contagious respiratory ill-
ness caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), which is responsible for the COVID-19
pandemic. The first case of novel coronavirus was reported
in Wuhan, Hubei province, China, in December 2019 [1].
The examination of the disease suggests that the outbreak was
associated with the seafood market in Wuhan. Coronavirus is
a closed Ribonucleic Ac-id (RNA) that is classified among hu-
mans, other mammals, and birds. There are six types of coro-
navirus species that infect humans. Four of these viruses that
commonly cause the common cold are 229E, OC43, NL63,
and HKU1 [2]. The other two viruses, namely SARS-COV
and MERS-COV, are linked to humans’ fatal illnesses [3].
The World Health Organization (WHO) declared the outbreak
of COVID-19 pneumonia as a pan-demic in March 2020.
Globally, as of 10th June 2021, there have been 174,061,995
confirmed cases of COVID-19, including 3,758,560 deaths,
reported to the World Health Organization (WHO) [4]. The
symptoms of the disease are varied. Common symptoms
include respiratory illness, cough, headache, loss of smell
and taste, nasal congestion, muscle pain, sore throat, fever,
and diarrhea. The presence of the virus in the human body
was identified by using sequencing in samples from patients
with pneumonia [2]. The present diagnosis for coronavirus
includes reverse-transcription polymerase chain reaction (RT-
PCR), real-time RT-PCR (rRT-PCR), and reverse transcription
loop-mediated isothermal amplification (RT-LAMP). Other
tests also involve nasopharyngeal and oropharyngeal swab
tests to detect COVID-19. However, these tests are time-
consuming, and the shortage of kits delays the diagnosis [5].
Other than these tests, computed tomography (CT) scans and
chest X-rays (CXR) are used to detect COVID-19 pneumonia.
The COVID-19 pandemic is still a primary challenge for the
healthcare sector, especially in rural and developing regions
with a significant shortage of medical personnel.
Artificial intelligence (AI) attempts to build intelligent mod-
els and includes machine learning and deep learning sub-
sets. Deep learning methods can enhance the image features
which are not visible in the original image [6]. Computed
tomography of the chest utilizes X-ray apparatus to investigate
abnormalities found in tomography tests and to help diagnose
the reason for the shortness of breath, fever, chest pain, and
other chest symptoms. Computed tomography is accurate,
painless, and non-invasive, and it can detect tiny nodules in
the lung. Early detection of cases of COVID-19 pneumonia
for timely treatment is crucial for avoiding the spread of the
epidemic [7]. Nonetheless, this remains a difficult task to be
completed. A vast number of patients across different locations
and the limited medical resources cause a delay in early
detection, resulting in delayed decisions on hospitalizations,
which increases the chances of cross-infections and poor
prognosis. The current RT-PCR test to determine COVID-19
infection has some limitations. The current test (RT-PCR) is
not available universally, the processing time can be lengthy,
and the sensitivity report varies. As new studies come up, we
cannot solely rely on the RT-PCR test for diagnosing COVID-
19, especially in patients without symptoms [8], [9]. It is
challenging to distinguish between the CT scans of COVID-19
pneumonia patients and general pneumonia patients because
arXiv:2210.09403v2 [eess.IV] 26 Oct 2022